908 Devices Inc (MASS)
5.62
+0.06
(+1.08%)
USD |
NASDAQ |
Apr 24, 16:00
5.605
-0.02
(-0.27%)
After-Hours: 20:00
908 Devices Cash from Investing (TTM): -26.40M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -26.40M |
| September 30, 2023 | -31.65M |
| June 30, 2023 | -36.24M |
| March 31, 2023 | -16.38M |
| December 31, 2022 | -15.81M |
| September 30, 2022 | -15.25M |
| June 30, 2022 | -0.801M |
| Date | Value |
|---|---|
| March 31, 2022 | -1.345M |
| December 31, 2021 | -0.737M |
| September 30, 2021 | -0.683M |
| June 30, 2021 | -0.45M |
| March 31, 2021 | 0.073M |
| December 31, 2020 | -0.009M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-36.24M
Minimum
Jun 2023
0.073M
Maximum
Mar 2021
-11.21M
Average
-1.345M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
| Perspective Therapeutics Inc | 24.37M |
| Retractable Technologies Inc | -10.76M |
| Xtant Medical Holdings Inc | -24.78M |
| Asensus Surgical Inc | 64.51M |
| Catheter Precision Inc | -0.061M |